#lx9851 (1 Posts)
-
Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment Novo Nordisk acquires global rights to Lexicon's obesity drug LX9851, aiming to enhance its position in the obesity treatment market.
Hot Topics